Afuco™ Anti-FAP ADCC Therapeutic Antibody (Sibrotuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to FAP. Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-211 |
| Pricing | Inquiry |
| Host | Human |
| Target | FAP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IP, FC, FuncS, Neut, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |